Shengjian Huang

Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance

Zhihong Liu, Hongtao Song, Zai-zhong Zhang, 2023, Frontiers in Pharmacology.

CS27109, A Selective Thyroid Hormone Receptor-β Agonist Alleviates Metabolic-Associated Fatty Liver Disease in Murine Models

Jing Liu, Zhou-lin Deng, D. Pan, 2023, International journal of endocrinology.

Targeting ASK1 by CS17919 alleviates kidney- and liver-related diseases in murine models.

Shengjian Huang, Guoqiang Liao, Yiru Zhao, 2024, Animal models and experimental medicine.